Acro Biomedical (ACBM) Non-Current Assets (2017 - 2025)
Acro Biomedical (ACBM) posted Non-Current Assets of $13651.0 for Q2 2025, down 32.83% on a QoQ basis from $20324.0 in Q1 2025, and down 69.22% year-over-year from $44355.0 in Q2 2024.
Powered by 
Analysis
Acro Biomedical (ACBM) Non-Current Assets (2017 - 2025) Analysis & Trends
Acro Biomedical has reported Non-Current Assets for 9 years, with the latest figure at $13651.0 in Q2 2025.
- On a quarterly basis, Non-Current Assets fell 69.22% year-over-year to $13651.0 in Q2 2025; TTM through Jun 2026 was $13651.0, a 86.19% decrease from a year earlier, with the FY2024 full-year figure at $26898.0, down 52.67% from the prior year.
- Non-Current Assets was $13651.0 for Q2 2025 at Acro Biomedical, down from $20324.0 in the prior quarter.
- The five-year high for Non-Current Assets was $56833.0 in Q4 2023, with the low at $6268.0 in Q3 2021.
- Average Non-Current Assets over 5 years is $29931.8, with a median of $28423.5 recorded in 2022.
- The sharpest annual moves came in 2021 and 2024: Non-Current Assets sank 82.07% in 2021, then jumped 481.9% in 2024.
- Over 5 years, Non-Current Assets stood at $54662.0 in 2021, then plunged by 45.21% to $29949.0 in 2022, then surged by 89.77% to $56833.0 in 2023, then plunged by 52.67% to $26898.0 in 2024, then plunged by 49.25% to $13651.0 in 2025.
- The last three Non-Current Assets figures came in at $13651.0 (Q2 2025), $20324.0 (Q1 2025), and $26898.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 10.48 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 20.84 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 12.20 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 3.11 Bn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 3.06 Bn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 5.16 Bn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 1.69 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 2.42 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 3.66 Mn |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 13,651.00 |
| Mar 31, 2025 | 20,324.00 |
| Dec 31, 2024 | 26,898.00 |
| Sep 30, 2024 | 37,975.00 |
| Jun 30, 2024 | 44,355.00 |
| Mar 31, 2024 | 50,641.00 |
| Dec 31, 2023 | 56,833.00 |
| Sep 30, 2023 | 6,526.00 |
| Jun 30, 2023 | 12,988.00 |
| Mar 31, 2023 | 19,385.00 |
| Dec 31, 2022 | 29,949.00 |
| Sep 30, 2022 | 36,220.00 |
| Jun 30, 2022 | 42,429.00 |
| Mar 31, 2022 | 48,576.00 |
| Dec 31, 2021 | 54,662.00 |
| Sep 30, 2021 | 6,268.00 |
| Jun 30, 2021 | 12,474.00 |
| Mar 31, 2021 | 18,618.00 |
| Dec 30, 2020 | 24,700.00 |
| Sep 30, 2020 | 34,951.00 |